Attitudes of family medicine residents in Ankara towards COVID-19 vaccines administered in Turkey: a descriptive, cross-sectional study
Hüsna Sarca Çevk, Rana Baykan, Aye Peker, Selda Tekner
{"title":"Attitudes of family medicine residents in Ankara towards COVID-19 vaccines administered in Turkey: a descriptive, cross-sectional study","authors":"Hüsna Sarca Çevk, Rana Baykan, Aye Peker, Selda Tekner","doi":"10.5114/fmpcr.2022.115871","DOIUrl":null,"url":null,"abstract":"Background. The difficulty of accessing accurate information during the COVID-19 pandemic resulted in many questions being asked to family physicians about vaccination. Objectives. The aim of this study was to determine the attitudes of Family Medicine (FM) residents in Ankara about the inactivated and mRNA COVID-19 vaccines being administered in Turkey. Material and methods. An anonymous online survey was distributed to FM residents between 22.05.2021–06.06.2021. Information on socio-demographic data and residents’ attitudes towards COVID-19 vaccines administered in Turkey were evaluated. Results. 11.1% of the participants were not vaccinated for the following reasons: having positive Anti-Spike antibody values, think-ing that there had not been enough studies on vaccines, vaccine safety concerns, belief that innate immunity would be more pro-tective, pregnancy, breastfeeding or not believing in the protection of the vaccine. While 12.2% of the participants recommended Sinovac-CoronaVac, 23.7% recommended Pfizer/BioNTech, and 63.3% stated that they would evaluate the patient and make recom-mendations. Most of the participants stated that they thought the Pfizer/BioNTech is more protective against new variants (70.4%), more effective and produces a higher antibody response (84.2%) and provides longer-term protection (74.8%). However, 74.1% of the participants stated that they thought Sinovac-CoronaVac is safer. Sinovac-CoronaVac was recommended to patients with a history of allergic reaction/anaphylaxis (69.8%), autoimmune diseases (60.4%), oncology/chemotherapy patients (49.6%), immunosuppressed patients (49.6) and lactating women (44.6%). Conclusions. In some case-basis recommendations, it was seen that the residents showed a traditionalist approach. Informing individuals based on scientific information on the safety and effectiveness of the COVID-19 vaccines by family physicians is crucial. © by Wydawnictwo Continuo.","PeriodicalId":305591,"journal":{"name":"Family Medicine & Primary Care Review","volume":"25 4","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Family Medicine & Primary Care Review","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5114/fmpcr.2022.115871","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background. The difficulty of accessing accurate information during the COVID-19 pandemic resulted in many questions being asked to family physicians about vaccination. Objectives. The aim of this study was to determine the attitudes of Family Medicine (FM) residents in Ankara about the inactivated and mRNA COVID-19 vaccines being administered in Turkey. Material and methods. An anonymous online survey was distributed to FM residents between 22.05.2021–06.06.2021. Information on socio-demographic data and residents’ attitudes towards COVID-19 vaccines administered in Turkey were evaluated. Results. 11.1% of the participants were not vaccinated for the following reasons: having positive Anti-Spike antibody values, think-ing that there had not been enough studies on vaccines, vaccine safety concerns, belief that innate immunity would be more pro-tective, pregnancy, breastfeeding or not believing in the protection of the vaccine. While 12.2% of the participants recommended Sinovac-CoronaVac, 23.7% recommended Pfizer/BioNTech, and 63.3% stated that they would evaluate the patient and make recom-mendations. Most of the participants stated that they thought the Pfizer/BioNTech is more protective against new variants (70.4%), more effective and produces a higher antibody response (84.2%) and provides longer-term protection (74.8%). However, 74.1% of the participants stated that they thought Sinovac-CoronaVac is safer. Sinovac-CoronaVac was recommended to patients with a history of allergic reaction/anaphylaxis (69.8%), autoimmune diseases (60.4%), oncology/chemotherapy patients (49.6%), immunosuppressed patients (49.6) and lactating women (44.6%). Conclusions. In some case-basis recommendations, it was seen that the residents showed a traditionalist approach. Informing individuals based on scientific information on the safety and effectiveness of the COVID-19 vaccines by family physicians is crucial. © by Wydawnictwo Continuo.
安卡拉家庭医学居民对在土耳其接种的COVID-19疫苗的态度:一项描述性横断面研究
背景。由于在COVID-19大流行期间难以获得准确信息,因此向家庭医生提出了许多关于疫苗接种的问题。目标。本研究的目的是确定安卡拉家庭医学(FM)居民对土耳其正在接种的COVID-19灭活疫苗和mRNA疫苗的态度。材料和方法。一项匿名在线调查于2021年5月22日至2021年6月6日期间向FM居民分发。评估了土耳其社会人口统计数据和居民对COVID-19疫苗的态度。结果:11.1%的参与者未接种疫苗的原因如下:抗spike抗体阳性、认为疫苗研究不够、疫苗安全性问题、认为先天免疫更有保护作用、怀孕、哺乳或不相信疫苗的保护作用。12.2%的参与者推荐Sinovac-CoronaVac, 23.7%的参与者推荐Pfizer/BioNTech, 63.3%的参与者表示会对患者进行评估并提出建议。大多数参与者表示,他们认为辉瑞/BioNTech对新变异的保护更强(70.4%),更有效,产生更高的抗体反应(84.2%),提供更长期的保护(74.8%)。然而,74.1%的参与者表示他们认为华锐科-冠乐创更安全。有过敏反应/过敏反应史(69.8%)、自身免疫性疾病(60.4%)、肿瘤/化疗患者(49.6%)、免疫抑制患者(49.6%)和哺乳期妇女(44.6%)推荐使用Sinovac-CoronaVac。结论。在一些基于个案的建议中,可以看到居民表现出传统的做法。家庭医生根据科学信息向个人通报COVID-19疫苗的安全性和有效性至关重要。©by Wydawnictwo Continuo。
本文章由计算机程序翻译,如有差异,请以英文原文为准。